MedPath

Manganese

Generic Name
Manganese
Brand Names
Concept Ob, Multitrace-4, Multitrace-5, Multrys, Tandem Plus
Drug Type
Small Molecule
Chemical Formula
Mn
CAS Number
7439-96-5
Unique Ingredient Identifier
H6EP7W5457

Overview

Manganese is a transition metal with a molar mass of 54.94g/mol. Manganese is considered critical for human health, and plays important roles in development, metabolism, and the antioxidant system. That said, excessive manganese intake is associated with manganism, a neurodegenerative disorder that causes dopaminergic neuronal death and parkinsonian-like symptoms.

Background

Manganese is a transition metal with a molar mass of 54.94g/mol. Manganese is considered critical for human health, and plays important roles in development, metabolism, and the antioxidant system. That said, excessive manganese intake is associated with manganism, a neurodegenerative disorder that causes dopaminergic neuronal death and parkinsonian-like symptoms.

Indication

Indicated for use as a supplement to intravenous solutions given for Total Parenteral Nutrition (TPN). Administration helps to maintain plasma levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.

Associated Conditions

No associated conditions information available.

FDA Approved Products

Strovite One Caplets
Manufacturer:Exeltis USA, Inc.
Route:ORAL
Strength:1.5 mg in 1 1
Approved: 2023/01/02
NDC:0642-0207
Ligatend Liquescence
Manufacturer:Nutritional Specialties, Inc.
Route:ORAL
Strength:12 [hp_X] in 1 mL
Approved: 2025/04/14
NDC:83027-0036
MANGANESE
Manufacturer:Hospira, Inc.
Route:INTRAVENOUS
Strength:0.1 mg in 1 mL
Approved: 2023/12/06
NDC:0409-4091
MetDetox
Manufacturer:Dr. Donna Restivo DC
Route:ORAL
Strength:8 [hp_X] in 1 mL
Approved: 2025/05/23
NDC:62185-0062

Singapore Approved Products

ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION
Manufacturer:Fresenius Kabi Norge AS
Form:INFUSION, SOLUTION CONCENTRATE
Strength:19.79 mcg/ml
Online:Yes
Approved: 2017/07/24
Approval:SIN15302P
PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION
Manufacturer:FRESENIUS KABI NORGE AS
Form:INJECTION
Strength:3.6 mcg/ml
Online:Yes
Approved: 1996/09/04
Approval:SIN08899P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath